参考文献/References:
[1].1Mozaffarian D,Benjamin EJ,Benjamin EJ,et al. Heart disease and stroke statistics—2016 update:a report from the American Heart Association[J]. Circulation,2016,133(4):e38-e360.
[2].Li Y,Wu YF,Chen KP,et al. Prevalence of atrial fibrillation in China and its risk factors[J]. Biomed Environ Sci,2013,26(9):709-716.
[3].Monteiro P,em nome dos investigadores do estudo Safira. The SAFIRA study:a reflection on the prevalence and treatment patterns of atrial fibrillation and cardiovascular risk factors in 7 500 elderly subjects[J]. Rev Port Cardiol,2018,37(4):307-313.
[4].[European Heart Rhythm Association,European Association for Cardio-Thoracic Surgery,Camm AJ,et al. Guidelines for the management of atrial fibrillation:the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)[J]. Eur Heart J,2010,31:2369-2429.
[5].Patti G,Pengo V,Marcucci R,et al. The left atria appendage:from embryology to prevention of thromboembolism[J]. Eur Heart J,2017,38(12):877-887..
[6].Regazzoli D,Ancona F,Trevisi N,et al. Left atrial appendage:physiology,pathology,and role as a therapeutic target[J]. Biomed Res Int,2015,2015:205013.
[7].熊婧,陈维. 经皮左心耳封堵术研究回顾与展望[J]. 中国介入心脏病学杂志,2018,26(10):589-592.
[8].[8Kong B,Liu Y,Hu H,et al. Left atrial appendage morphology in patients with atrial fibrillation in China:implications for stroke risk assessment from a single center study[J]. Chin Med J,2014,127(24):4210-4214.
[9].[9] Lee K,Park SJ,Kwon HJ,et al. Progressive increase in peridevice leakage after the implantation of the watchman device on long-term serial echocardiographic follow-up[J]. Can J Cardiol,2014,30(11):1461.e15-17.
[10].Koizumi R,Funamoto K,Hayase T,et al. Numerical analyis of hemodynamic changes in the left atrium due to atrial fibrllation[J]. J Biomech,2014,48(3):472-478.
[11].Camm AJ,Camm CF,Savelieva I. Medical treatment of atrial fibrillation[J]. J Cardiovasc Med(Hagerstown),2012,13:97-107.
[12]. 陈施羽,常静. 经皮左心耳封堵术与射频导管消融术对心房颤动脑卒中预防效果研究[J]. 心血管病学进展,2018,39(2):173-176.
[13].[13Blackshrar JL,Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation[J]. Ann Thorac Surg,1996,61:755-759.
[14].Sievert H,Lesh MD,Trepels T,et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high risk patients with atrial fibrillation:early clinical experience[J]. Circulation,2002,105:1887-1889.
[15].Ostermayer SH,Reisman M,Kramer PH,et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation:results from the international multi-center feasibility trials[J]. J Am Colle Cardiol,2005,46(1):9-14.
[16]. Park JW,Leith?user B,Gerk U,et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes[J].? J Invasive Cardiol,2009,21:446-450.
[17].Food and Drug Administration. Circulatory Devices Panel Meeting:April23.2009,briefing information[EB/OL]. Accessed May26,2009 at http://www.fda.gov/ohrms/dockets/ac/09/briefing/2009-4434b1-00-Index.html.
[18]. Reddy VY,Doshi SK,Kar S,et al. 5-year outcomes after left atrial appendage closure:From the PREVAIL and PROTECTAF Trials[J]. J Am Coll Cardiol,2017,70(24):2964-2975.
[19]. Boersma LV,Ince H,Kische S,et al. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation:1-year follow-up outcome data of the EWOLUTION trial[J]. Heart Rhythm,2017,14(9):1302-1308.
[20]. Holmes DR Jr,Kar S,Price MJ,et al. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy:the PREVAIL trial[J]. J Am Coll Cardiol,2014,64(1):1-12.
[21]. Holmes DR Jr,Doshi SK,Kar S,et al. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation:a patient-level meta-analysis[J]. J Am Coll Cardiol,2015,65(24):2614-2623.
[22]. Reddy VY,M?bius-Winkler S,Miller MA,et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)[J]. ?J Am Coll Cardiol,2013,61:2551-2556.
[23]. Holmes DR,Reddy VY,Buchbinder M,et al. The assessment of the watchman device in patients unsuitable for oral anticoagulation (ASAP-TOO) trial[J].?Am Heart J,2017,189:68-74.
[24]. Landmesser U,Schmidt B,Nielsen-Kudsk JE,et al. Left atrial appendage occlusion with the AMPLATZER Amulet device:periprocedural and early clinical/echocardiograpic data from a global prospective observational study[J]. EuroIntervention,2017,13(7):867-876.
[25]. Figini F,Mazzone P,Regazzoli D,et al. Left atrial appendage closure:a single center experience and comparison of two contemporary devices[J]. Catheter Cardiovasc Interv,2017,89(4):763-772.
[26]. Huang H,Liu Y,Xu Y,et al. Percutaneous left atrial appendage closure with the LAmbre device for stroke prevention in atrial fibrillation:a prospective,multicenter clinical study[J]. JACC Cardiovasc Interv,2017,10(21):2188-2194.
[27].Park JW,Sievert H,Kleinecke C,et al. Left atrial appendage occlusion with lambre in atrial fibrillation:initial European experience[J]. Int J Cardiol,2018,265:97-102.
[28]. Chen S,Schmidt B,Bordignon S,et al. Feasibility of percutaneous left atrial appendage closure using a novel LAmbre occluder in patients with atrial fibrillation:initial results from a prospective cohort registry study[J]. J Cardiovasc Electrophysiol,2018,29(2):291-297.
[29]. Xu H,Xie X,Wang B,et al. Efficacy and safety of percutaneous left atrial appendage occlusion for stroke prevention in nonvalvular atrial fibrillation: a meta-analysis of contemporary studies[J].?Heart Lung Circ,2016,25:1107-1117.?
[30].Betts TR,Leo M,Panikker S,et al. Percutaneous left atrial appendage occlusion using different technologies in the United Kingdom: a multicenter registry[J].?Catheter Cardiovasc Interv,2017,89:484-492.
[31].Fauchier L,Cinaud A,Brigadeau F,et al. Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation[J]. J Am Coll Cardiol,2018,71(14):158.
[32].Bergmann MW,Betts TR,Sievert H,et al. Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective,multicentre,monitored international WATCHMAN LAA closure registry[J].?EuroIntervention,2017,13:877-884.
[33]. Tilz RR,Potpara T,Chen J,et al. Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey[J].?Europace,2017,19:1737-1742.
[34].Meier B,Blaauw Y,Khattab AA,et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion[J].?EuroIntervention,2015,10:1109-1125.
[35].Schellinqer PD,Tsivqoulis G,Steiner T,et al. Percutaneous?left?atrial appendage occlusion for the?prevention?of?stroke?in?patients?with?atrial?fibrillation:review and Critical Appraisal[J]. J Stroke,2018,20(3):281-291.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(8):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(8):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(8):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(8):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(8):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
[11]王燕凤 刘汉雄 童兰 汪汉 张翠 成联超 蔡琳.左心耳电压分布规律的观察性研究[J].心血管病学进展,2020,(4):419.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.022]
WANG Yanfeng,LIU Hanxiong,TONG Lan,et al.Voltage Mapping of Left Atrial Appendage:Observational Study[J].Advances in Cardiovascular Diseases,2020,(8):419.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.022]
[12]林明宽.左心耳与心房颤动的关系[J].心血管病学进展,2022,(4):362.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.018]
LIN Mingkuan.Left Atrial Appendage and Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(8):362.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.018]
[13]樊永强吕华胜 刘佳琦汤宝鹏 周贤惠 李耀东 邢强 张疆华 芦颜美.心房颤患者左心耳与导管消融后复发的相关性：单中心研究[J].心血管病学进展,2023,(10):949.[doi:10.16806/j.cnki.issn.1004-3934.202.10.019]
FAN Yongqiang,LIU Jiaqi,LYU Huasheng,et al.Correlation Between Left Atrial Appendage Dysfunction and Recurrence after Catheter Ablation in Patients with Atrial Fibrillation:A Single Center Study[J].Advances in Cardiovascular Diseases,2023,(8):949.[doi:10.16806/j.cnki.issn.1004-3934.202.10.019]